{"slug":"ss-31-muscle-loss","verification":{"valid":true,"entries":2,"head":"50172c91001aedb95ad7ba36fe0e7c20a285d46358a7686b2d3ab41118ec8264"},"energy":{"passes":2,"tokens_in":19688,"tokens_out":2926,"tokens_total":22614,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"50172c91001aedb95ad7ba36fe0e7c20a285d46358a7686b2d3ab41118ec8264"},"provenance":[{"ts":"2026-06-29T23:51:53.770Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Muscle Loss\nSlug: ss-31-muscle-loss\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do no","response":"{\n  \"slug\": \"ss-31-muscle-loss\",\n  \"title\": \"SS-31 (Elamipretide) for Muscle Loss: Mitochondrial Evidence Breakdown\",\n  \"body\": \"## What's breaking down\\n\\nMuscle loss with age, often called sarcopenia, involves multiple layers. One key layer is mitochondrial decline inside muscle cells. Mitochondria produce ATP for contraction and repair. With age, they generate more reactive oxygen species, lose efficiency in oxidative phosphorylation, and show reduced ADP sensitivity. This leads to lower energy output, oxidative damage to proteins, and impaired muscle performance and maintenance. If mitochondrial dysfunction outpaces repair mechanisms, muscle mass and strength decline over time.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. If mitochondrial oxidative stress and poor ATP production contribute to your muscle loss, SS-31 binds cardiolipin in the inner mitochondrial membrane. 2. This stabilizes the membrane, improves electron transport chain efficiency, and lowers excess ROS production. 3. Therefore for you: If that layer is part of your problem, SS-31 is discussed because it targets repair (tissue) — not because it masks pain. 4. Better mitochondrial function can support muscle fiber maintenance and fatigue resistance instead of allowing further breakdown.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer of degeneration. If your profile includes other layers like inflammation or hormonal decline, additional approaches would address those separately.\\n\\n## What the evidence actually shows\\n\\nPreclinical studies in aged mice show SS-31 improves skeletal muscle mitochondrial ATP production, reverses age-related redox stress, increases fatigue resistance, and boosts exercise tolerance (Campbell et al. 2019; Siegel et al. 2013). One 2026 rat model of HFpEF found it improved soleus and EDL muscle contractile function and prevented atrophy development. A 2022 mouse study after spinal cord injury found no pre","tokens_in":19688,"tokens_out":2926,"cost":0,"prev":"genesis","hash":"1369e0bd23f42dc3d720becb7e4fecdf3c0ce157788a4eb0d95f6fd8a47287cd"},{"ts":"2026-07-17T02:42:05.916Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-muscle-loss","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1369e0bd23f42dc3d720becb7e4fecdf3c0ce157788a4eb0d95f6fd8a47287cd","hash":"50172c91001aedb95ad7ba36fe0e7c20a285d46358a7686b2d3ab41118ec8264"}]}